
Spine sales surpassed $10.4 billion in 2023 and accounted for 18% of the $59 billion global orthopedic market. It is the second largest segment in orthopedics while also boasting the most product launches, M&A transactions and funding announcements over the last decade.
Although spine has intense industry interest and highly favorable patient demographics, growth in core fusion products has slowed to the low single digits. Companies are increasingly turning to new avenues of growth and new treatment options.
Our latest report highlights spine market sales, M&A activity, leading market forces and top companies.
Submit this Form to Access the Report
*We respect your privacy. By completing this form, you are choosing to provide us with personal information. Under no circumstance will we lease, sell or share your information with any other person or entity.